NO920942D0 - Konjugert vaksine for gruppe b streptococcus - Google Patents

Konjugert vaksine for gruppe b streptococcus

Info

Publication number
NO920942D0
NO920942D0 NO920942A NO920942A NO920942D0 NO 920942 D0 NO920942 D0 NO 920942D0 NO 920942 A NO920942 A NO 920942A NO 920942 A NO920942 A NO 920942A NO 920942 D0 NO920942 D0 NO 920942D0
Authority
NO
Norway
Prior art keywords
streptococcus
group
conjugated vaccine
vaccine
conjugated
Prior art date
Application number
NO920942A
Other languages
English (en)
Other versions
NO313908B1 (no
NO920942L (no
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Original Assignee
Gen Hospital Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Brigham & Womens Hospital filed Critical Gen Hospital Corp
Publication of NO920942D0 publication Critical patent/NO920942D0/no
Publication of NO920942L publication Critical patent/NO920942L/no
Publication of NO313908B1 publication Critical patent/NO313908B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19920942A 1989-09-15 1992-03-11 FremgangsmÕte for fremstilling av en konjugatvaksine, rekombinant molekyl samt fremgangsmÕte for fremstilling av etantiserum NO313908B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15
PCT/US1990/005251 WO1991004049A1 (en) 1989-09-15 1990-09-14 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS)

Publications (3)

Publication Number Publication Date
NO920942D0 true NO920942D0 (no) 1992-03-11
NO920942L NO920942L (no) 1992-05-12
NO313908B1 NO313908B1 (no) 2002-12-23

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19920942A NO313908B1 (no) 1989-09-15 1992-03-11 FremgangsmÕte for fremstilling av en konjugatvaksine, rekombinant molekyl samt fremgangsmÕte for fremstilling av etantiserum

Country Status (22)

Country Link
EP (1) EP0491865B1 (no)
JP (2) JPH05500455A (no)
KR (1) KR0180559B1 (no)
AT (1) ATE146081T1 (no)
AU (1) AU641439B2 (no)
CA (2) CA2383393A1 (no)
DE (1) DE69029396T2 (no)
DK (1) DK0491865T3 (no)
ES (1) ES2097154T3 (no)
FI (1) FI105154B (no)
GR (1) GR1002294B (no)
HU (1) HU219327B (no)
IE (1) IE903349A1 (no)
IL (1) IL95578A (no)
NO (1) NO313908B1 (no)
NZ (1) NZ235316A (no)
PL (3) PL167444B1 (no)
PT (1) PT95316A (no)
RU (1) RU2113234C1 (no)
WO (1) WO1991004049A1 (no)
YU (1) YU176490A (no)
ZA (1) ZA907297B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
JP4163251B2 (ja) * 1992-09-24 2008-10-08 ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド グループｂストレプトコッカス・タイプ▲ｉｉ▼およびタイプ▲ｖ▼多糖−蛋白質接合ワクチン
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
SG47049A1 (en) * 1993-03-19 1998-03-20 Gunnar Lindahl Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6444787B1 (en) 1997-12-31 2002-09-03 Research Development Institute, Inc. Method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine
JP2008525033A (ja) * 2004-12-22 2008-07-17 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｂ群連鎖球菌

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
DE3750139T2 (de) * 1986-04-16 1994-10-06 Brigham & Womens Hospital Bakterielle antigene, antikörper, impfstoffe und deren herstellung.
WO1989000583A1 (en) * 1987-07-17 1989-01-26 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species

Also Published As

Publication number Publication date
GR1002294B (el) 1996-05-03
ZA907297B (en) 1993-06-01
IE903349A1 (en) 1991-04-10
WO1991004049A1 (en) 1991-04-04
PL167882B1 (pl) 1995-11-30
JP2001309795A (ja) 2001-11-06
NZ235316A (en) 1992-11-25
GR900100692A (el) 1992-01-20
DE69029396D1 (de) 1997-01-23
NO313908B1 (no) 2002-12-23
KR920703097A (ko) 1992-12-17
KR0180559B1 (ko) 1999-03-20
PL168587B1 (pl) 1996-03-29
FI921111A0 (fi) 1992-03-13
RU2113234C1 (ru) 1998-06-20
PL286898A1 (en) 1991-06-03
YU176490A (sh) 1992-12-21
HUT63770A (en) 1993-10-28
IL95578A0 (en) 1991-06-30
NO920942L (no) 1992-05-12
AU641439B2 (en) 1993-09-23
CA2066221C (en) 2002-07-23
EP0491865A1 (en) 1992-07-01
JP3447713B2 (ja) 2003-09-16
PT95316A (pt) 1991-06-25
ES2097154T3 (es) 1997-04-01
ATE146081T1 (de) 1996-12-15
EP0491865A4 (en) 1993-05-05
IL95578A (en) 1998-08-16
FI105154B (fi) 2000-06-30
JPH05500455A (ja) 1993-02-04
CA2383393A1 (en) 1991-04-04
PL167444B1 (pl) 1995-09-30
EP0491865B1 (en) 1996-12-11
AU6519090A (en) 1991-04-18
DK0491865T3 (da) 1997-06-02
CA2066221A1 (en) 1991-03-16
DE69029396T2 (de) 1997-06-05
HU219327B (en) 2001-03-28

Similar Documents

Publication Publication Date Title
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO920942D0 (no) Konjugert vaksine for gruppe b streptococcus
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
DK205585A (da) Polysaccharidproteinkonjugat, fremgangsmaade til fremstilling deraf ogpraeparat omfattende et polysaccharidproteinkonjugat
DK0549617T3 (da) Forbedrede vaccinepræparater
DE69627149D1 (de) Antigene polysaccharidfragmente mit einer terminalen 2,5-anhydro-d-mannosegruppevon gruppe b-streptococcus, typ ii und typ iii, und daraus hergestellte konjugatimpfstoffe
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
DE69231663D1 (de) Konjugate bestehend aus polysaccharid und protein
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK0610179T3 (da) Målspecifikke antistof-superantigenkonjugater og fremstilling deraf
ES475509A1 (es) Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae.
ES2131066T3 (es) Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
KR900014598A (ko) 변형된 pe_40의 제조
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
GR1000396B (el) Νεο ολιγομερες παραγωγον πολυαιθοξυλιωμενης λιπαρας αμινης-η μεθοδος παραγωγης αυτου-η εφαρμογη του δια την τροποποιησιν των επιφανειακων ιδιοτητων των πολυμερων.